NEW YORK, Nov. 8, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The global customer relationship management (CRM)…
Final step before the full launch of breast cancer screening program, Revealia™SPARKS, NV / ACCESSWIRE / November 7, 2024 /…
NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced their planned presence at the International Society for Pharmacoeconomics and Outcomes Research Europe (ISPOR…
NEW YORK, Nov. 5, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global online doctor consultation…
Company Poised to Revolutionize Breast Cancer Screening through AI-based Risk Prediction BOSTON, Nov. 5, 2024 /PRNewswire/ -- Clairity, Inc., a…
The Behavioral Health Tech 2024 (BHT2024) conference is a premier event dedicated to advancing access to mental health, substance use,…
MENLO PARK, Calif., Nov. 4, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect…
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studiesCollaboration underscores Lonza's commitment to…
VICTORIA, BC / ACCESSWIRE / November 1, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announces that that…
Partnership aims to reduce barriers to care by putting patients in control of their own health journey and enabling nightly…